The Sun article regarding the U.S. Supreme Court and the pharmaceutical industry ("Drug industry tallies 2 high-court victories," June 24), reports how a decision of the court is "shielding the makers of generic drugs from most lawsuits filed by injured patients." Something is wrong when the incomplete copy of a patented drug is treated better than the original.

A patient injured by a generic drug needs some avenue for corrective action. Suing the manufacturer should at least be a patient's last recourse. Other avenues for recourse should be to the pharmacy that switches a prescription from the doctor's selection to the generic, or the doctor himself if he prescribed the generic.

Somewhere or somehow, the patient deserves a line of recourse for his or her injury when caused by a substitute drug that is not as complete as the original.

Richard Allchin, Cockeysville